"Designing Growth Strategies is in our DNA"

Oncology Drugs Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Last Updated: April 08, 2024 | Format: PDF | Report ID: FBI103431

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Cancer,  By Region/Country, 2021/2022
    2. Overview of Different Oncology Drugs With Respect to Regulatory Approvals and Clinical Trials
    3. Pricing Analysis, Key Brands / Key Players, 2022
    4. Key Industry Development (Mergers, Acquisitions and Partnerships)
    5. Impact of COVID-19 on the Market
  5. Global Oncology Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Oncology Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
        1. By Drug Class
      2. Canada
        1. By Drug Class
  7. Europe Oncology Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K
        1. By Drug Class
      2. Germany
        1. By Drug Class
      3. France
        1. By Drug Class
      4. Spain
        1. By Drug Class
      5. Italy
        1. By Drug Class
      6. Scandinavia
        1. By Drug Class
      7. Rest of Europe
        1. By Drug Class
  8. Asia Pacific Oncology Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
        1. By Drug Class
      2. China
        1. By Drug Class
      3. India
        1. By Drug Class
      4. Australia
        1. By Drug Class
      5. Southeast Asia
        1. By Drug Class
      6. Rest of Asia Pacific
        1. By Drug Class
  9. Latin America Oncology Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
        1. By Drug Class
      2. Mexico
        1. By Drug Class
      3. Rest of Latin America
        1. By Drug Class
  10. Middle East & Africa Oncology Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cytotoxic Drugs
        1. Alkylating Agents
        2. Antimetabolites
        3. Others
      2. Targeted Drugs
        1. Monoclonal Antibodies
        2. Others
      3. Hormonal Drugs
      4. Others
    2. Market Analysis, Insights and Forecast – By Therapy
      1. Chemotherapy
      2. Targeted Therapy
      3. Immunotherapy
    3. Market Analysis, Insights and Forecast – By Indication
      1. Lung Cancer
      2. Stomach Cancer
      3. Colorectal Cancer
      4. Breast Cancer
      5. Prostate Cancer
      6. Others
    4. Market Analysis, Insights and Forecast – By Dosage Form
      1. Solid
        1. Tablets
        2. Capsules
      2. Liquid
      3. Injectable
        1. Prefilled Syringes
        2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC
        1. By Drug Class
      2. South Africa
        1. By Drug Class
      3. Rest of Middle East & Africa
        1. By Drug Class
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Genentech, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Bristol Myers Squibb Company
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. GlaxoSmithKline plc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. AstraZeneca
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Sanofi
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Bayer AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      11. Merck & Co., Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Global Oncology Drugs Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 2:  Global Oncology Drugs Market Value Share (%), by Drug Class, 2022 & 2030

Figure 3:  Global Oncology Drugs Market Forecast (USD billion), by Cytotoxic Drugs, 2019-2030

Figure 4:  Global Oncology Drugs Market Forecast (USD billion), by Targeted Drugs, 2019-2030

Figure 5:  Global Oncology Drugs Market Value Share (%), by Therapy, 2022 & 2030

Figure 6:  Global Oncology Drugs Market Value Share (%), by Indication, 2022 & 2030

Figure 7:  Global Oncology Drugs Market Value Share (%), by Dosage Form, 2022 & 2030

Figure 8:  Global Oncology Drugs Market Forecast (USD billion), by Solid, 2019-2030

Figure 9:  Global Oncology Drugs Market Forecast (USD billion), by Injectable, 2019-2030

Figure 10:  Global Oncology Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 11:  Global Oncology Drugs Market Value (USD billion), by Region, 2022 & 2030

Figure 12:  North America Oncology Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 13:  North America Oncology Drugs Market Value Share (%), by Drug Class, 2022

Figure 14:  North America Oncology Drugs Market Value (USD billion), by Therapy, 2022 & 2030

Figure 15:  North America Oncology Drugs Market Value Share (%), by Therapy, 2022

Figure 16:  North America Oncology Drugs Market Value (USD billion), by Indication, 2022 & 2030

Figure 17:  North America Oncology Drugs Market Value Share (%), by Indication, 2022

Figure 18:  North America Oncology Drugs Market Value (USD billion), by Dosage Form, 2022 & 2030

Figure 19:  North America Oncology Drugs Market Value Share (%), by Dosage Form, 2022

Figure 20:  North America Oncology Drugs Market Value (USD billion), by End-user, 2022 & 2030

Figure 21:  North America Oncology Drugs Market Value Share (%), by End-user, 2022

Figure 22:  North America Oncology Drugs Market Value (USD billion), By Country, 2022 & 2030

Figure 23:  North America Oncology Drugs Market Value Share (%), By Country, 2022

Figure 24:  Europe Oncology Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 25:  Europe Oncology Drugs Market Value Share (%), by Drug Class, 2022

Figure 26:  Europe Oncology Drugs Market Value (USD billion), by Therapy, 2022 & 2030

Figure 27:  Europe Oncology Drugs Market Value Share (%), by Therapy, 2022

Figure 28:  Europe Oncology Drugs Market Value (USD billion), by Indication, 2022 & 2030

Figure 29:  Europe Oncology Drugs Market Value Share (%), by Indication, 2022

Figure 30:  Europe Oncology Drugs Market Value (USD billion), by Dosage Form, 2022 & 2030

Figure 31:  Europe Oncology Drugs Market Value Share (%), by Dosage Form, 2022

Figure 32:  Europe Oncology Drugs Market Value (USD billion), by End-user, 2022 & 2030

Figure 33:  Europe Oncology Drugs Market Value Share (%), by End-user, 2022

Figure 34:  Europe Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 35:  Europe Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 36:  Asia Pacific Oncology Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 37:  Asia Pacific Oncology Drugs Market Value Share (%), by Drug Class, 2022

Figure 38:  Asia Pacific Oncology Drugs Market Value (USD billion), by Therapy, 2022 & 2030

Figure 39:  Asia Pacific Oncology Drugs Market Value Share (%), by Therapy, 2022

Figure 40:  Asia Pacific Oncology Drugs Market Value (USD billion), by Indication, 2022 & 2030

Figure 41:  Asia Pacific Oncology Drugs Market Value Share (%), by Indication, 2022

Figure 42:  Asia Pacific Oncology Drugs Market Value (USD billion), by Dosage Form, 2022 & 2030

Figure 43:  Asia Pacific Oncology Drugs Market Value Share (%), by Dosage Form, 2022

Figure 44:  Asia Pacific Oncology Drugs Market Value (USD billion), by End-user, 2022 & 2030

Figure 45:  Asia Pacific Oncology Drugs Market Value Share (%), by End-user, 2022

Figure 46:  Asia Pacific Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 47:  Asia Pacific Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 48:  Latin America Oncology Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 49:  Latin America Oncology Drugs Market Value Share (%), by Drug Class, 2022

Figure 50:  Latin America Oncology Drugs Market Value (USD billion), by Therapy, 2022 & 2030

Figure 51:  Latin America Oncology Drugs Market Value Share (%), by Therapy, 2022

Figure 52:  Latin America Oncology Drugs Market Value (USD billion), by Indication, 2022 & 2030

Figure 53:  Latin America Oncology Drugs Market Value Share (%), by Indication, 2022

Figure 54:  Latin America Oncology Drugs Market Value (USD billion), by Dosage Form, 2022 & 2030

Figure 55:  Latin America Oncology Drugs Market Value Share (%), by Dosage Form, 2022

Figure 56:  Latin America Oncology Drugs Market Value (USD billion), by End-user, 2022 & 2030

Figure 57:  Latin America Oncology Drugs Market Value Share (%), by End-user, 2022

Figure 58:  Latin America Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 59:  Latin America Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 60:  Middle East & Africa Oncology Drugs Market Value (USD billion), by Drug Class, 2022 & 2030

Figure 61:  Middle East & Africa Oncology Drugs Market Value Share (%), by Drug Class, 2022

Figure 62:  Middle East & Africa Oncology Drugs Market Value (USD billion), by Therapy, 2022 & 2030

Figure 63:  Middle East & Africa Oncology Drugs Market Value Share (%), by Therapy, 2022

Figure 64:  Middle East & Africa Oncology Drugs Market Value (USD billion), by Indication, 2022 & 2030

Figure 65:  Middle East & Africa Oncology Drugs Market Value Share (%), by Indication, 2022

Figure 66:  Middle East & Africa Oncology Drugs Market Value (USD billion), by Dosage Form, 2022 & 2030

Figure 67:  Middle East & Africa Oncology Drugs Market Value Share (%), by Dosage Form, 2022

Figure 68:  Middle East & Africa Oncology Drugs Market Value (USD billion), by End-user, 2022 & 2030

Figure 69:  Middle East & Africa Oncology Drugs Market Value Share (%), by End-user, 2022

Figure 70:  Middle East & Africa Oncology Drugs Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 71:  Middle East & Africa Oncology Drugs Market Value Share (%), By Country/ Sub-region, 2022

Figure 72:  Global Oncology Drugs Market Share (%), By Company, 2022

Table 1:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019–2030

Table 2:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 3:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 4:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019–2030

Table 5:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019–2030

Table 6:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019–2030

Table 7:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2030

Table 8:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2030

Table 9:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by End-user, 2019–2030

Table 10:  Global Oncology Drugs Market Revenue (USD billion) Forecast, by Region, 2019-2030

Table 11:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 12:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 13:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 14:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2030

Table 15:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 16:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2030

Table 17:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2030

Table 18:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2030

Table 19:  North America Oncology Drugs Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 20:  North America Oncology Drugs Market Revenue (USD billion) Forecast, By Country, 2019-2030

Table 21:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 22:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 23:  U.S. Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 24:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 25:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 26:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 27:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2030

Table 28:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 29:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2030

Table 30:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2030

Table 31:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2030

Table 32:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 33:  Europe Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 34:  U.K. Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 35:  U.K. Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 36:  U.K. Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 37:  Germany Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 38:  Germany Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 39:  Germany Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 40:  France Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 41:  France Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 42:  France Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 43:  Italy Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 44:  Italy Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 45:  Italy Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 46:  Spain Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 47:  Spain Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 48:  Spain Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 49:  Scandinavia Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 50:  Scandinavia Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 51:  Scandinavia Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 52:  Rest of Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 53:  Rest of Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 54:  Rest of Europe Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 55:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 56:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 57:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 58:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2030

Table 59:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 60:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2030

Table 61:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2030

Table 62:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2030

Table 63:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 64:  Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 65:  China Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 66:  China Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 67:  China Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 68:  India Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 69:  India Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 70:  India Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 71:  Japan Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 72:  Japan Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 73:  Japan Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 74:  Australia Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 75:  Australia Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 76:  Australia Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 77:  Southeast Asia Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 78:  Southeast Asia Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 79:  Southeast Asia Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 80:  Rest of Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 81:  Rest of Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 82:  Rest of Asia Pacific Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 83:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 84:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 85:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 86:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2030

Table 87:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 88:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2030

Table 89:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2030

Table 90:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2030

Table 91:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 92:  Latin America Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 93:  Brazil Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 94:  Brazil Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 95:  Brazil Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 96:  Mexico Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 97:  Mexico Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 98:  Mexico Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 99:  Rest of Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 100:  Rest of Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 101:  Rest of Latin America Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 102:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 103:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 104:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 105:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Therapy, 2019-2030

Table 106:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 107:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Dosage Form, 2019-2030

Table 108:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Solid, 2019–2030

Table 109:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Injectable, 2019–2030

Table 110:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 111:  Middle East & Africa Oncology Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 112:  GCC Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 113:  GCC Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 114:  GCC Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 115:  South Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 116:  South Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 117:  South Africa Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Table 118:  Rest of Middle East Oncology Drugs Market Revenue (USD billion) Forecast, by Drug Class, 2019-2030

Table 119:  Rest of Middle East Oncology Drugs Market Revenue (USD billion) Forecast, by Cytotoxic Drugs, 2019–2030

Table 120:  Rest of Middle East Oncology Drugs Market Revenue (USD billion) Forecast, by Targeted Drugs, 2019–2030

Oncology Drugs Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 190
  • Buy Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X